Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism THBS1 antagonists(Thrombospondin 1 antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Progressive pulmonary fibrosis | Phase 1 | CN | 08 Jul 2024 | |
Idiopathic Pulmonary Fibrosis | IND Application | CN | 30 Jan 2022 | |
Solid tumor | Preclinical | CN | 30 Jan 2022 |